Bausch Health CFO reports tax-withheld RSU shares

Bausch Health Companies Inc. executive vice president and CFO Jean-Jacques Charhon reported a tax-related share disposition.

Accepted by SEC EDGAR 03/03/2026 - 05:45 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Bausch Health Companies Inc. executive vice president and CFO Jean-Jacques Charhon reported a tax-related share disposition. On the vesting of Restricted Share Units, 49,060 common shares at $5.93 per share were withheld to cover tax obligations, a non-market transaction. After this withholding, Charhon directly holds 706,478 common shares.

Insider Trade Summary

Exercise Price or Tax Liability: 49,060 shares

Exercise Price or Tax Liability 1 txn

Insider Charhon Jean-Jacques

Role EVP, CFO

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Shares, No Par Value	49,060	$5.93	$291K

Holdings After Transaction: Common Shares, No Par Value — 706,478 shares (Direct)

Holdings Before and After: Common Shares, No Par Value, 755,538 to 706,478 shares (Direct)

Footnotes (1)

1. F1. This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Bausch Health (BHC) executive Jean-Jacques Charhon report on this Form 4?

Jean-Jacques Charhon reported a tax-withholding disposition of Bausch Health common shares. 49,060 shares were withheld to satisfy taxes due upon RSU vesting, rather than sold in the open market, and these are recorded as a disposal.

How many Bausch Health (BHC) shares were withheld for taxes in Charhon’s transaction?

The filing shows 49,060 Bausch Health common shares withheld at $5.93 per share. These shares were retained by the issuer to cover tax obligations triggered when Charhon’s Restricted Share Units vested, rather than being a discretionary stock sale.

What is Jean-Jacques Charhon’s Bausch Health (BHC) share ownership after this Form 4?

After the tax-withholding disposition, Jean-Jacques Charhon directly holds 706,478 common shares of Bausch Health. This figure reflects his remaining direct ownership after the issuer withheld 49,060 shares to satisfy tax obligations associated with Restricted Share Unit vesting.

Was the Bausch Health (BHC) Form 4 transaction an open-market sale by Charhon?

No, the transaction was a tax-withholding disposition, not an open-market sale. Shares were withheld by the issuer to pay taxes due upon Restricted Share Unit vesting, as described in the footnote, rather than sold at Charhon’s discretion on the market.

What does transaction code F mean in the Bausch Health (BHC) Form 4 for Charhon?

Transaction code F indicates payment of an exercise price or tax liability using securities. In this case, 49,060 Bausch Health shares were withheld to satisfy Charhon’s tax obligations when Restricted Share Units vested, consistent with a standard tax-settlement mechanism.

How is the nature of ownership classified for Charhon’s Bausch Health (BHC) shares?

The filing classifies Charhon’s holdings as direct ownership, indicated by the code “D.” After the tax-withholding disposition related to Restricted Share Units, his directly owned Bausch Health common shares total 706,478, as reported in the post-transaction ownership field.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Charhon Jean-Jacques

(Last) (First) (Middle)

400 SOMERSET CORPORATE BLVD.

(Street)

BRIDGEWATER NJ 08807

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Bausch Health Companies Inc. [ BHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, CFO

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares, No Par Value	02/27/2026		F		49,060(1)	D	$5.93	706,478	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

	/s/ Brianna M. Dorsi attorney-in-fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.